FANCD2 and Miyoshi myopathy: Second, it reduces monoubiquitination of FANCD2 and polyubiquitylation of γH2AX in cancer cell lines and inhibits the formation of DNA damage foci (BRCA1 and RAD51 foci) in MM cell lines [246,247,248].